Precision Medicine Will Advance Through Widespread Adoption of NGS
Next-generation sequencing is at the forefront of the precision medicine revolution, offering the promise to empower tailored patient care.
Read MorePosted by Chris Wolski | Dec 18, 2023 | Molecular Diagnostics |
Next-generation sequencing is at the forefront of the precision medicine revolution, offering the promise to empower tailored patient care.
Read MorePosted by Andy Lundin | Dec 13, 2023 | Lung Cancer |
Freenome’s PROACT LUNG study is intended to validate the clinical performance of its blood test for lung cancer screening.
Read MorePosted by Andy Lundin | Dec 13, 2023 | Lung Cancer |
DELFI Diagnostics is supporting the recently introduced Lung Cancer Screening and Prevention Act (H.R. 6693).
Read MorePosted by Andy Lundin | Dec 12, 2023 | Lung Cancer |
Liquid biopsies could predict which lung cancer patients are responding to immunotherapies or may develop immune-related side effects.
Read MorePosted by Andy Lundin | Dec 11, 2023 | Cancer, Digital Pathology |
Researchers at UT Southwestern Medical Center developed a novel AI model that analyzes the spatial arrangement of cells in tissue samples.
Read More